Expose Russia Olympic Bribes: Olympic Bribes and Construction Bribes Can Be The Basis of Large Whistleblower Rewards

Expose Russia Olympic Bribes: Olympic Bribes and Construction Bribes Can Be The Basis of Large Whistleblower Rewards by International Whistleblower Lawyer Jason S. Coomer

Russian whistleblowers, public officials, business professionals, employees of multinational corporations, and others that have evidence of Russian government corruption are eligible for large whistleblower financial rewards.  Russian government corruption that can be the basis for these
awards include illegal payments for business; bribes for construction contracts; illegal incentives for oil, gas and mineral leases; illegal kickbacks for regulatory approval; and other violations of Foreign
Corrupt Practices Act (FCPA).  Russian whistleblowers and multinational corporation whistleblowers are needed to step up to report illegal corrupt practices and can receive large financial rewards for being the first to properly expose significant Russian government corruption.

If you are aware of a significant Foreign Corrupt Practice Act (FCPA) violation, please feel free to go to the following webpage: Russian Whistleblower Rewards or contact Russian Government Whistleblower  Lawyer, Jason Coomer via e-mail message. 

Contractor flees Russia after refusing to pay Olympic bribes - CBS News

"A new report by a Russian anti-corruption group says the total cost for the games has soared to about $50 billion -- more than five times as much as the last winter games.  Yet the best place to discover why costs have risen so high may not be among the gleaming new venues, but on a street in a town just outside London, where Valery Morozov, once an Olympic contractor -- now a fugitive -- lives."

"Miscalculated, he said, because the local Olympic organizers told him to add about $30 million
to his bill for various Sochi construction projects, and then pay that money back to them as kickbacks."

"The only one reason for this was their pockets," Morozov said. "There was only one reason." Morozov rebuilt some of the crumbling facilities of the old Sochi resort. The kickbacks, he said, followed a familiar formula. The kickback was about 40 percent of the total contract." 

Expose Illegal Medical Device, Medical Equipment, and Pharmaceutical Bribes: International Whistleblower Reward Lawyer Jason S. Coomer

The SEC Is Offering Large Rewards To International Whistleblowers That Can Properly Expose Medical Device Bribes, Medical Equipment Bribes, and Pharmaceutical Bribes to Physicians by International Whistleblower Lawyer Jason S. Coomer

International whistleblowers can recover large amounts of money for exposing international pharmaceutical and medical device bribes.  By exposing procurement kickbacks, medicine supply chain bribes, and other violations of the Foreign Corrupt Practices Act, a physician or other whistleblower can not only help expose corruption, but can receive a large reward.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of
specialized knowledge of international drug company bribes, international pharmaceutical company illegal kickback schemes, medical device and equipment procurement bribery schemes, and other illicit payments for drug procurement, medical device procurement, and medical equipment contracts.

For more information on a potential Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please go to the following web page: Medical Device, Medical Equipment, and Pharmaceutical Bribe Lawsuits or please feel free to send an e-mail message to International Whistleblower Reward Lawyer Jason Coomer. 

SEC.gov | SEC Charges Stryker Corporation With FCPA Violations

An SEC investigation found that Stryker Corporation’s subsidiaries in Argentina, Greece, Mexico, Poland, and Romania made illicit payments totaling approximately $2.2 million that were incorrectly described as legitimate expenses in the company’s books and records.  Descriptions varied from a charitable donation to consulting and service contracts, travel expenses, and commissions.  Stryker made approximately $7.5 million in illicit profits as a result of the improper payments.

Stryker has agreed to pay more than $13.2 million to settle the SEC’s charges.

Johnson & Johnson

The SEC alleges that, since at least 1998, J&J’s subsidiaries paid bribes to public doctors in Greece who selected J&J surgical implants, paid bribes to public doctors and hospital administrators in
Poland who awarded tenders to J&J, and paid bribes to public doctors in Romania to prescribe J&J pharmaceutical products. J&J also paid kickbacks to Iraq in order to obtain contracts under the United Nations Oil for Food Program (“Program”).

J&J has agreed to pay more than $48.6 million in disgorgement and prejudgment interest to settle the SEC’s charges and to pay a $21.4 million fine to the U.S. Department of Justice to settle criminal
charges. A resolution of a related investigation by the United Kingdom Serious Fraud Office is anticipated.

The SEC’s complaint alleges that J&J subsidiaries, employees, and agents paid bribes to public doctors and administrators in Greece, Poland, and Romania. Doctors who ordered or prescribed J&J products were rewarded in a variety of ways, including cash and inappropriate travel. A variety of schemes were used to carry-out the bribery, including the use of slush funds, sham civil contracts with doctors, and off-shore companies in the Isle of Man. A J&J executive was involved in the Greek conduct, and MD&D Poland executives running three business lines oversaw the creation of sham contracts, travel documents, and the creation of slush funds in Poland. The SEC’s complaint also alleges that J&J’s agent paid secret kickbacks to Iraq to obtain nineteen Oil for Food contracts.

Public Health Care Bribes To Government Officials: Glaxo CEO on U.K. China Trade Mission Amid Bribery Probe - Bloomberg

Public Health Care Bribes To Government Officials Can Be The Basis For Large Whistleblower Rewards by International Public Health Care Bribe Lawyer Jason S. Coomer

International whistleblowers can recover large amounts of money for exposing international medicine procurement kickbacks, medicine supply chain bribes, and other violations of the Foreign Corrupt Practices Act.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of specialized knowledge of international drug company bribes, international pharmaceutical company illegal kickback schemes, public health medicine procurement bribery schemes, and other illicit payments for drug procurement, medical device procurement, medication, pharmaceutical, and medical equipment contracts.

For more information on this topic and confidential reviews of Public Health Care Bribe Whistleblower Reward Lawsuits, please go to the following web page:  International Medicine Bribe Whistleblower Reward Law Center.

Each Year Approximately $1 Trillion In Public Health Care Contracts Are Obtained Through Bribes and Illegal Kickbacks

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $750 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicines, pharmaceuticals, medical equipment, and medical devices is lost to corrupt and fraudulent acts.  These acts include government official bribes, illegal kickbacks, and other illicit payment and fraud schemes.

Glaxo CEO on U.K. China Trade Mission Amid Bribery Probe - Bloomberg

Glaxo agreed last year to pay a record $3 billion fine in the U.S. to settle allegations that the company illegally marketed medicines. That settlement came with a “Corporate Integrity Agreement” with the U.S. government that requires Glaxo to report any investigation or legal proceedings.

“Ongoing risks include the global regulatory fallout, foremost in the U.S., from any repercussions in China,” Kepler Cheuvreux’s environmental, social and governance research team said in a report on corruption in the pharmaceutical industry last month.

Anti-corruption investigations may also spill over to other countries such as India, Brazil and Russia, especially during election years, according to Kepler analyst Sudip Hazra.
“They could potentially use these precedents in the U.S. and China to embolden them politically,” Hazra said.

International Public Health Bribes and Whistleblower Rewards: SEC Charges Pfizer with FCPA Violations | Investor.gov

International Whistleblower Reward Laws Offer Financial Rewards and Bounties to International Whistleblowers That Expose Illegal Bribes to Government Officials by Confidential International Illegal Bribe Whistleblower Lawyer Jason S. Coomer

International whistleblowers can recover large rewards for exposing international medicine procurement kickbacks, public health care bribes, and other violations of the Foreign Corrupt Practices Act.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of specialized knowledge of international bribes and illegal kickbacks are encouraged to contact an international whistleblower lawyer to have their whistleblower reward case confidentially reviewed.

For more information on a potential Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please go to the following web page on International Public Health Care Bribe Whistleblower Reward Lawsuits or use our submission form.

SEC Charges Pfizer with FCPA Violations | Investor.gov

The SEC alleges that employees and agents of Pfizer’s subsidiaries in Bulgaria, China, Croatia, Czech Republic, Italy, Kazakhstan, Russia, and Serbia made improper payments to foreign officials to obtain regulatory and formulary approvals, sales, and increased prescriptions for the company’s pharmaceutical products. They tried to conceal the bribery by improperly recording the transactions in accounting records as legitimate expenses for promotional activities, marketing, training, travel and entertainment, clinical trials, freight, conferences, and advertising.

The SEC separately charged another pharmaceutical company that Pfizer acquired a few years ago – Wyeth LLC – with its own FCPA violations. Pfizer and Wyeth agreed to separate settlements in which they will pay more than $45 million combined to settle their respective charges. In a parallel action, the Department of Justice announced that Pfizer H.C.P. Corporation agreed to pay a $15 million penalty to resolve its investigation of FCPA violations.

“Pfizer subsidiaries in several countries had bribery so entwined in their sales culture that they offered points and bonus programs to improperly reward foreign officials who proved to be their best customers,” said Kara Brockmeyer, Chief of the SEC Enforcement Division’s Foreign Corrupt Practices Act Unit. “These charges illustrate the pitfalls that exist for companies that fail to appropriately monitor potential risks in their global operations.”

According to the SEC’s complaint against Pfizer filed in U.S. District Court for the District of Columbia, the misconduct dates back as far as 2001. Employees of Pfizer’s subsidiaries authorized and made cash payments and provided other incentives to bribe government doctors to utilize Pfizer products. In China, for example, Pfizer employees invited “high-prescribing doctors” in the Chinese government to club-like meetings that included extensive recreational and entertainment activities to reward doctors’ past product sales or prescriptions. Pfizer China also created various “point programs” under which government doctors could accumulate points based on the number of Pfizer prescriptions they wrote. The points were redeemed for various gifts ranging from medical books to cell phones, tea sets, and reading glasses. In Croatia, Pfizer employees created a “bonus program” for Croatian doctors who were employed in senior positions in Croatian government health care institutions. Once a doctor agreed to use Pfizer products, a percentage of the value purchased by a doctor’s institution would be funneled back to the doctor in the form of cash, international travel, or free products.

Foreign Corrupt Practices Act SEC Bounty Actions, Whistleblower Rewards, and Confidential Reviews by International Foreign Corrupt Practices Act Bounty Action Lawyer Jason S. Coomer

Foreign Corrupt Practices Act SEC Fraud Whistleblower Bounty Actions Are Designed to Expose Significant SEC and FCPA Violations by Offering Large Financial Rewards to People That Are The Original Source of Information That Expose Illegal Bribes, Kickbacks, and other SEC FCPA Violations by International FCPA Lawyer

SEC Fraud Whistleblower Lawsuits or SEC Bounty Actions are a product of the enactment of the Dodd-Frank Wall Street Reform and Consumer Protection Act.  These laws were designed to create bounties that can be collected by whistleblowers that properly report Foreign Corrupt Practices violations, illegal brides, kickback schemes, money laundering, SEC violations, international financial fraud, securities fraud, and commodities fraud that result in monetary sanctions over one million dollars ($1,000,000.00).  The SEC can award the whistleblower up to 30% of the money collected.

By creating whistleblower bounties for investors and people with specific information of fraud, it is expected that hard to detect fraud will be exposed to help regulate the financial market and prevent large investment corporations, banks, hedge funds, and other large corporations from committing financial fraud of billions of dollars.  Further, new whistleblower protection laws allow potential whistleblowers to confidentially report potential bounty actions through a lawyer.  These protections allow professionals to protect their identities and career while having a potential bounty action reviewed.

- See more at: SEC Bounty Actions and Confidential Reviews

 International Illegal Bribery Schemes Can Be The Basis of SEC Bounty Actions

The Foreign Corrupt Practices Act (FCPA) prohibits bribery of foreign officials by U.S. and foreign companies listed on the U.S. securities exchange.  The FCPA also requires such companies to maintain accurate books and records.  Foreign Corrupt Practices Act Whistleblowers that properly report violations of the FCPA by a U.S. or foreign company listed on the U.S. securities exchanges can recover a large reward for exposing FCPA violations.


If you are aware of a significant Foreign Corrupt Practice Act  violation, please feel free to contact Foreign Corrupt Practices Act Whistleblower Reward Lawyer Jason Coomer via e-mail message or go to the following web site: International Illegal Bribery Schemes and International Whistleblower Reward Information

Foreign Corrupt Practices Act Whistleblower Rewards by Confidential Foreign Corrupt Practices Act Whistleblower Lawyer Jason S. Coomer

Foreign Corrupt Practices Act Whistleblowers Can Received Large Financial Rewards For Exposing International Bribes, Illegal Kickbacks, Slush Funds, and other Illegal Activities by International Foreign Corrupt Practices Lawyer Jason S. Coomer

The Foreign Corrupt Practices Act and the new SEC Whistleblower Incentive Program work together to reward whistleblowers with original and specialized knowledge and evidence of international business corporate bribery and illegal kickbacks.  These new international business whistleblower reward laws are part of a worldwide movement to expose and punish government corruption such as contract bribes, illegal kickbacks, and large scale international fraud.  These Foreign Corrupt Practices Act should help prevent government corruption in many countries including Russia, China, Mexico, and Brazil.

• China Foreign Corrupt Practices Act Violation Whistleblower Lawyer
• China Port Official Bribe Whistleblower Reward Lawyer
• China Port Official Bribe Whistleblower Reward Lawsuits 在中国
• International Medicine Procurement Bribe Whistleblower Lawyer
• Brazilian Government Official Bribe Whistleblower Bounty Action Lawyer
• Brazil Contract Bribe FCPA Bounty Actions Em Português
• Mexico Gestores Government Official Bribe Lawyer
• Mexico Contract Bribe FCPA Bounty Action Lawyer
• Mexico Contract Bribe FCPA Bounty Actions en Español
• Russian Government Corruption Whistleblower Reward Bounty Action Lawyer
• Юрист, занимающийся делами о взятках государственным
• должностным лицам в России
• South America Foreign Corporation Illegal Bribe Whistleblower Lawyer
• Foreign Corrupt Practices Act Lawyer and SEC Bounty Action Claim Lawyer
• International Contract Government Official Bribe Bounty Action Lawyer
• Corporate Illegal Kickback & Contract Bribe Whistelblower Award Lawyer
• International Oil Company Fraud Whistleblower Lawyer

For more information on this topic, please go to the following web page:  International Business Bribery Whistleblower Reward Lawyer.

Parker Drilling Company (Release No. LR-22672; April 16, 2013)

Parker Drilling Company (Release No. LR-22672; April 16, 2013)

SEC Charges Parker Drilling Company with Violating the Foreign Corrupt Practices Act

The Securities and Exchange Commission today charged Parker Drilling Company, a worldwide drilling services and project management firm, with violating the Foreign Corrupt Practices Act (FCPA) by authorizing improper payments to a third-party intermediary retained to assist the company in resolving customs disputes.

The SEC's complaint, filed in federal district court in Alexandria, Virginia, alleges that in 2004 Parker Drilling authorized payments to a Nigerian agent totaling $1.25 million. The company did so despite former senior executives knowing that the agent intended to use the funds to "entertain" Nigerian officials involved in resolving Parker Drilling's ongoing customs problems. Following the Nigerian agent's work, the company received an unexplained $3,050,000 reduction of a previously assessed customs fine, and the company was permitted to nationalize and sell its Nigerian rigs.

To settle the SEC's charges, Parker Drilling will pay disgorgement of $3,050,000 plus pre-judgment interest of $1,040,818. Parker Drilling consented to the entry of a final judgment permanently enjoining it from violating Sections 30A, 13(b)(2)(A), and 13(b)(2)(B) of the Exchange Act. The proposed settlement is subject to court approval.

In the parallel criminal proceedings, the Department of Justice entered into a Deferred Prosecution Agreement with Parker Drilling in which the company will pay an $11,760,000 penalty.